Heterogeneous tumor subpopulations cooperate to drive invasion

Cell Reports

Volumn 8, Issue 3, 2014, Pages 688-695

  Chapman, Anna ^a   del Ama, Laura Fernandez ^a   Ferguson, Jennifer ^a   Kamarashev, Jivko ^b   Wellbrock, Claudia ^a   Hurlstone, Adam ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; FIBRONECTIN; MATRIX METALLOPROTEINASE; MT1 PROTEIN; UNCLASSIFIED DRUG; MATRIX METALLOPROTEINASE 14; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ASSAY; CELL FUNCTION; CELL HETEROGENEITY; CELL INVASION; CELL SUBPOPULATION; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; EMBRYO; EXTRACELLULAR MATRIX; MELANOMA; MELANOMA CELL; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; TUMOR CELL; TUMOR MICROENVIRONMENT; TUMOR XENOGRAFT; ANIMAL; CELL MOTION; CLASSIFICATION; GENETICS; HUMAN; MELANOCYTE; METABOLISM; NUCLEAR REPROGRAMMING; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; TUMOR INVASION; ZEBRA FISH;

DANIO RERIO;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; CELLULAR REPROGRAMMING; EXTRACELLULAR MATRIX; HUMANS; MATRIX METALLOPROTEINASE 14; MELANOCYTES; MELANOMA; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; NEOPLASM INVASIVENESS; PHENOTYPE; ZEBRAFISH;

EID: 84921690361     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2014.06.045     Document Type: Article

References (34)

1. Arozarena, I., Bischof, H., Gilby, D., Belloni, B., Dummer, R., and Wellbrock, C. (2011). In melanoma, beta-catenin is a suppressor of invasion. Oncogene 30, 4531-4543.
2. Carreira, S., Goodall, J., Denat, L., Rodriguez, M., Nuciforo, P., Hoek, K.S., Testori, A., Larue, L., and Goding, C.R. (2006). Mitf regulation of Dia1 controls melanoma proliferation and invasiveness. Genes Dev. 20, 3426-3439.
3. Cleary, A.S., Leonard, T.L., Gestl, S.A., and Gunther, E.J. (2014). Tumour cell heterogeneity maintained by cooperating subclones in Wnt-driven mammary cancers. Nature 508, 113-117.
4. Friedland, J.C., Lee, M.H., and Boettiger, D. (2009). Mechanically activated integrin switch controls alpha5beta1 function. Science 323, 642-644.
5. Gaggioli, C., Deckert, M., Robert, G., Abbe, P., Batoz, M., Ehrengruber, M.U., Ortonne, J.P., Ballotti, R., and Tartare-Deckert, S. (2005). HGF induces fibronectin matrix synthesis in melanoma cells through MAP kinase-dependent signaling pathway and induction of Egr-1. Oncogene 24, 1423-1433.
6. Gaggioli, C., Hooper, S., Hidalgo-Carcedo, C., Grosse, R., Marshall, J.F., Harrington, K., and Sahai, E. (2007). Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells. Nat. Cell Biol. 9, 1392-1400.
7. Greaves, M., and Maley, C.C. (2012). Clonal evolution in cancer. Nature 481, 306-313.
8. Hoek, K.S., and Goding, C.R. (2010). Cancer stem cells versus phenotypeswitching in melanoma. Pigment Cell Melanoma Res 23, 746-759.
9. Hoek, K.S., Schlegel, N.C., Brafford, P., Sucker, A., Ugurel, S., Kumar, R., Weber, B.L., Nathanson, K.L., Phillips, D.J., Herlyn, M., et al. (2006). Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature. Pigment Cell Res. 19, 290-302.
10. Hoek, K.S., Eichhoff, O.M., Schlegel, N.C., Döbbeling, U., Kobert, N., Schaerer, L., Hemmi, S., and Dummer, R. (2008). In vivo switching of human melanoma cells between proliferative and invasive states. Cancer Res. 68, 650-656.
11. Hou, J.M., Krebs, M.G., Lancashire, L., Sloane, R., Backen, A., Swain, R.K., Priest, L.J., Greystoke, A., Zhou, C., Morris, K., et al. (2012). Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer. J. Clin. Oncol. 30, 525-532.
12. Kamoshida, G., Matsuda, A., Miura, R., Takashima, Y., Katsura, A., and Tsuji, T. (2013). Potentiation of tumor cell invasion by co-culture with monocytes accompanying enhanced production of matrix metalloproteinase and fibronectin. Clin. Exp. Metastasis 30, 289-297.
13. Khoja, L., Shenjere, P., Hodgson, C., Hodgetts, J., Clack, G., Hughes, A., Lorigan, P., and Dive, C. (2014). Prevalence and heterogeneity of circulating tumour cells in metastatic cutaneous melanoma. Melanoma Res. 24, 40-46.
14. King, R., Weilbaecher, K.N., McGill, G., Cooley, E., Mihm, M., and Fisher, D.E. (1999). Microphthalmia transcription factor. A sensitive and specific melanocyte marker for MelanomaDiagnosis. Am. J. Pathol. 155, 731-738.
15. Levental, K.R., Yu, H., Kass, L., Lakins, J.N., Egeblad, M., Erler, J.T., Fong, S.F., Csiszar, K., Giaccia, A., Weninger, W., et al. (2009). Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 139, 891-906.
16. Ohanna, M., Giuliano, S., Bonet, C., Imbert, V., Hofman, V., Zangari, J., Bille, K., Robert, C., Bressac-de Paillerets, B., Hofman, P., et al. (2011). Senescent cells develop a PARP-1 and nuclear factor-kappaB-associated secretome (PNAS). Genes Dev. 25, 1245-1261.
17. Provenzano, P.P., Eliceiri, K.W., Campbell, J.M., Inman, D.R., White, J.G., and Keely, P.J. (2006). Collagen reorganization at the tumor-stromal interface facilitates local invasion. BMC Med. 4, 38.
18. Ramaswamy, S., Ross, K.N., Lander, E.S., and Golub, T.R. (2003). A molecular signature of metastasis in primary solid tumors. Nat. Genet. 33, 49-54.
19. Rozenberg, G.I., Monahan, K.B., Torrice, C., Bear, J.E., and Sharpless, N.E. (2010). Metastasis in an orthotopic murine model of melanoma is independent of RAS/RAF mutation. Melanoma Res. 20, 361-371.
20. Sabeh, F., Ota, I., Holmbeck, K., Birkedal-Hansen, H., Soloway, P., Balbin, M., Lopez-Otin, C., Shapiro, S., Inada, M., Krane, S., et al. (2004). Tumor cell traffic through the extracellular matrix is controlled by the membrane-anchored collagenase MT1-MMP. J. Cell Biol. 167, 769-781.
21. Sahai, E., and Marshall, C.J. (2003). Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis. Nat. Cell Biol. 5, 711-719.
22. Scheel, C., and Weinberg, R.A. (2012). Cancer stem cells and epithelialmesenchymal transition: concepts and molecular links. Semin. Cancer Biol. 22, 396-403.
23. Sottile, J., and Hocking, D.C. (2002). Fibronectin polymerization regulates the composition and stability of extracellular matrix fibrils and cell-matrix adhesions. Mol. Biol. Cell 13, 3546-3559.
24. Tsuji, T., Ibaragi, S., Shima, K., Hu, M.G., Katsurano, M., Sasaki, A., and Hu, G.F. (2008). Epithelial-mesenchymal transition induced by growth suppressor p12CDK2-AP1 promotes tumor cell local invasion but suppresses distant colony growth. Cancer Res. 68, 10377-10386.
25. Uhlen, M., Oksvold, P., Fagerberg, L., Lundberg, E., Jonasson, K., Forsberg, M., Zwahlen, M., Kampf, C., Wester, K., Hober, S., et al. (2010). Towards a knowledge-based Human Protein Atlas. Nat. Biotechnol. 28, 1248-1250.
26. Vakiani, E., Janakiraman, M., Shen, R., Sinha, R., Zeng, Z., Shia, J., Cercek, A., Kemeny, N., D'Angelica, M., Viale, A., et al. (2012). Comparative genomic analysis of primary versus metastatic colorectal carcinomas. J. Clin. Oncol. 30, 2956-2962.
27. Vignot, S., Frampton, G.M., Soria, J.C., Yelensky, R., Commo, F., Brambilla, C., Palmer, G., Moro-Sibilot, D., Ross, J.S., Cronin, M.T., et al. (2013). Nextgeneration sequencing reveals high concordance of recurrent somatic alterations between primary tumor and metastases from patients with nonsmall-cell lung cancer. J. Clin. Oncol. 31, 2167-2172.
28. Walter, M.J., Shen, D., Ding, L., Shao, J., Koboldt, D.C., Chen, K., Larson, D.E., McLellan, M.D., Dooling, D., Abbott, R., et al. (2012). Clonal architecture of secondary acute myeloid leukemia. N. Engl. J. Med. 366, 1090-1098.
29. Wellbrock, C., and Hurlstone, A. (2010). BRAF as therapeutic target in melanoma. Biochem. Pharmacol. 80, 561-567.
30. Wolf, K., Mazo, I., Leung, H., Engelke, K., von Andrian, U.H., Deryugina, E.I., Strongin, A.Y., Bröcker, E.B., and Friedl, P. (2003). Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis. J. Cell Biol. 160, 267-277.
31. Wolf, K., Wu, Y.I., Liu, Y., Geiger, J., Tam, E., Overall, C., Stack, M.S., and Friedl, P. (2007). Multi-step pericellular proteolysis controls the transition from individual to collective cancer cell invasion. Nat. Cell Biol. 9, 893-904.
32. Wolf, K., Te Lindert, M., Krause, M., Alexander, S., Te Riet, J., Willis, A.L., Hoffman, R.M., Figdor, C.G., Weiss, S.J., and Friedl, P. (2013). Physical limits of cell migration: control by ECM space and nuclear deformation and tuning by proteolysis and traction force. J. Cell Biol. 201, 1069-1084.
33. Wu, M., Pastor-Pareja, J.C., and Xu, T. (2010). Interaction between Ras(V12) and scribbled clones induces tumour growth and invasion. Nature 463, 545-548.
34. Yu, M., Bardia, A., Wittner, B.S., Stott, S.L., Smas, M.E., Ting, D.T., Isakoff, S.J., Ciciliano, J.C., Wells, M.N., Shah, A.M., et al. (2013). Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 339, 580-584.